title: [Effect of rapamycin on NF-kappaB induction].
authors.forename: Tomohito
authors.initials: T
authors.lastname: Kakegawa
authors.forename: Asayo
authors.initials: A
authors.lastname: Nemoto
authors.forename: Megumi
authors.initials: M
authors.lastname: Matsuda
authors.forename: Hiromi
authors.initials: H
authors.lastname: Saito
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kobayashi
mesh_terms: D017398:Alternative Splicing / Q000187:drug effects; D001402:B-Lymphocytes / Q000378:metabolism; D002478:Cells, Cultured; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008081:Liposomes / Q000378:metabolism; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D012261:Ribonucleoproteins / Q000378:metabolism; D020123:Sirolimus / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology
chemical_list: D020672:I-kappa B Proteins; D007166:Immunosuppressive Agents; D008081:Liposomes; D016328:NF-kappa B; C000606204:NFKBIA protein, human; D012333:RNA, Messenger; D012261:Ribonucleoproteins; C026452:messenger ribonucleoprotein; D000072000:NF-KappaB Inhibitor alpha; D020123:Sirolimus; D016559:Tacrolimus